Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases
This large trial addresses a critical gap by examining disease safety, efficacy, adverse effects, and immunogenicity, considering the impact of diverse therapies following recombinant zoster vaccine administration in ARD patients.
Authors
- Léonard de Vinci Kanda Kupa (ORCID: https://orcid.org/0000-0002-8827-1360)
- Carla Gonçalves Schahin Saad (ORCID: https://orcid.org/0000-0001-9720-0719)
- Clóvis A. Silva (ORCID: https://orcid.org/0000-0001-9250-6508)
- Vanderson de Souza Sampaio (ORCID: https://orcid.org/0000-0001-7307-8851)
- Percival D. Sampaio‐Barros (ORCID: https://orcid.org/0000-0001-9843-6686)
- Emily Figueiredo Neves Yuki (ORCID: https://orcid.org/0000-0001-8801-405X)
- Samuel Katsuyuki Shinjo (ORCID: https://orcid.org/0000-0002-3682-4517)
- Henrique A. M. Giardini
- Eduardo Ferreira Borba (ORCID: https://orcid.org/0000-0001-6194-5129)
- Eloísa Bonfá (ORCID: https://orcid.org/0000-0002-0520-4681)
- Andrea Yukie Shimabuco (ORCID: https://orcid.org/0000-0002-8511-5688)
- Ana Cristina de Medeiros Ribeiro (ORCID: https://orcid.org/0000-0001-7168-5906)
- Luciana Parente Costa Seguro (ORCID: https://orcid.org/0000-0003-0538-9476)
- Danieli Andrade
- Nádia Emi Aikawa (ORCID: https://orcid.org/0000-0002-7585-4348)
- Sandra Gofinet Pasoto (ORCID: https://orcid.org/0000-0002-7343-6804)
- Ana Paula Luppino Assad (ORCID: https://orcid.org/0000-0003-0516-6918)
- Júlio César Bertacini de Moraes (ORCID: https://orcid.org/0000-0002-5766-6802)
Institutions
- Instituto de Saúde (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1097/rhu.0000000000002216
- Citations
- 8
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 10.83